The company logo of JaxBio


Formerly known as JaxBio Technologies





0.7 years

At JaxBio, we use novel artificial intelligence (AI) algorithms to define sets of biomarkers that can identify different types and subtypes of cancer at various stages. At JaxBio we develop a blood test for fast, cheap and highly sensitive diagnosis of cancer.

Shahar Zirkin1
The profile picture of Yuval EbensteinYuval Ebenstein
The profile picture of Joel Bar-ElJoel Bar-ElChief Commercial Officer1
The profile picture of Dror FeldheimDror FeldheimExecutive Chairman1

RoundDateCapital RaisedInvestors
The company logo of JaxBioJaxBioGrant2023$9M1

ㅤInvestor NameInvestor TypeAUM ($)
The logo of EU Horizon EuropeEU Horizon EuropeGovernment


An AI algorithm is used to define a disease-specific panel that presents the strongest biomarkers that differentiate healthy and cancer states, as well as cancer type and stage. Our team has developed an ultra-sensitive method to detect genetic and epigenetic profiles in cell-free DNA, that occur during cancer initiation and progression. We extract cell-free DNA from a blood sample and fluorescently label markers utilizing a proprietary process. The DNA is hybridized onto our custom chip, and each cancer type presents a unique pixel pattern signature that may be used for classifying the type and stage of the disease.

You cannot copy content of this page

Add or Claim Your Profile

Submit the form below to add or claim an existing profile. 

Within 24 hours, we’ll review your request and connect you to your existing profile for full editing.

Sign up for free

  • Save profiles to your list
  • Basic search functionality

Get Notified on Changes to JaxBio's Profile

Fill in your email to get notifications of changes

🎉You're a power user!🎉

But we ask you to purchase a Pro subscription to continue browsing...

With a Pro subscription, you can enjoy unlimited profile viewing, export our entire database, and view verified email contacts. Power your innovation efforts, uninterrupted.